Savara Inc Cash Equivalents, at Carrying Value
Savara Inc (SVRA) had Cash Equivalents, at Carrying Value of $3.50 million as of 2016-12-31, per its 10-K filed 2017-03-06.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashEquivalentsAtCarryingValue · last filed 2017-03-06
- 2016-12-31: Cash Equivalents, at Carrying Value $3.50M.
- 2015-12-31: Cash Equivalents, at Carrying Value $15.80M.
- 2014-12-31: Cash Equivalents, at Carrying Value $16.60M.
- 2013-12-31: Cash Equivalents, at Carrying Value $1.30M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2016-12-31 | $3.50M 10-K · filed 2017-03-06 |
| 2015-12-31 | $15.80M 10-K · filed 2017-03-06 |
| 2014-12-31 | $16.60M 10-K · filed 2016-03-14 |
| 2013-12-31 | $1.30M 10-K · filed 2015-03-24 |
| 2012-12-31 | $1.00M 10-K · filed 2014-03-26 |
| 2011-12-31 | $2.90M 10-K · filed 2013-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |